• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NALU MEDICAL INC NALU NEUROSTIMULATION SYSTEM; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number 72012
Device Problem Migration (4003)
Patient Problem Inadequate Pain Relief (2388)
Event Date 03/05/2024
Event Type  Injury  
Manufacturer Narrative
It was noted during the field investigation that the patient is very thin, which likely contributed to the discomfort the patient was feeling from the implanted leads.The inadequate pain relief from the system is most likely related to one of the leads having migrated.It is unknown if the patient would have still been able to achieve adequate pain relief because the patient declined all troubleshooting and reprogramming that was offered and chose instead to explant the system.The explanted components were discarded by the medical facility, however there was no indication of any system or component failure.Lack of pain relief is likely due to the migrated lead, which is a known inherent risk of implantable neuromodulation systems.
 
Event Description
On (b)(6) 2023 the patient was implanted with a nalu peripheral nerve stimulator system targeting the occipital nerve to treat head pain and headaches.Patient had previously completed a trial phase with the nalu system and had reported pain was reduced from 7/10 to 1/10 during the trial.After completing the permanent system implant and initial activation of the system, the patient reported inadquate pain relief and discomfort with the placement of the implanted leads.Xray imaging found one of the implanted leads had migrated.Patient was offered reprogramming to attempt to attain adequate pain relief with the lead as-is and patient refused all attempts at troubleshooting.A full system explant was performed on (b)(6) 2024 per the patient request.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NALU NEUROSTIMULATION SYSTEM
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
NALU MEDICAL INC
2320 faraday avenue
suite 100
calsbad CA 92008
Manufacturer (Section G)
NALU MEDICAL, INC
2320 faraday ave
suite 100
carlsbad CA 92008 7241
Manufacturer Contact
rebecca hess
2320 faraday avenue
suite 100
carlsbad, CA 92008-7241
7604482360
MDR Report Key19047825
MDR Text Key339434611
Report Number3015425075-2024-00118
Device Sequence Number1
Product Code GZF
UDI-Device Identifier00812537035642
UDI-Public0100812537035642112102231724022310NJ811
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183579
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/23/2024
Device Model Number72012
Device Catalogue Number72012
Device Lot NumberNJ811
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/05/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/23/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-